S100-β serum protein - A new marker in the diagnosis and monitoring of langerhans cell histiocytosis? [6]

British Journal of Dermatology

Volumn 143, Issue 1, 2000, Pages 201-202

  Ugurel, S ^a   Pfohler, C ^a   Tilgen, W ^a   Reinhold, U ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CREATININE; PROTEIN S 100; RECOMBINANT ALPHA2B INTERFERON; UREA;

ADULT; CASE REPORT; FEMALE; HISTIOCYTOSIS X; HUMAN; LETTER; MONITORING; PRIORITY JOURNAL; PROGNOSIS; SKIN BIOPSY;

EID: 0033943334     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03622.x     Document Type: Letter

References (5)

1. 1 Yu RC, Chu C, Buluwela L, Chu AC. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet 1994 ; 343: 767–8.
2. 2 Komp DM. Langerhans cell histiocytosis. N Engl J Med 1987 ; 316: 747–8.
3. 3 Giona F, Caruso R, Testi AM et al. Langerhans’ cell histiocytosis in adults: a clinical and therapeutic analysis of 11 patients from a single institution. Cancer 1997 ; 80: 1786–91.
4. 4 Hauschild A, Engel G, Brenner W et al. Predictive value of serum S100B for monitoring patients with metastatic melanoma during chemotherapy and/or immunotherapy. Br J Dermatol 1999 ; 140: 1065–71.
5. 5 Jakobson AM, Kreuger A, Hagberg H, Sundstrom C. Treatment of Langerhans cell histiocytosis with alpha‐interferon. Lancet 1987 ; 2: 1520–1.